middle.news
Vectus Biosystems Appoints Dr Speranza and Raises $0.79M to Advance Fibrosis Pipeline
5:58pm on Tuesday 28th of July, 2026 AEST
•
Biotechnology
Read Story
Vectus Biosystems Appoints Dr Speranza and Raises $0.79M to Advance Fibrosis Pipeline
5:58pm on Tuesday 28th of July, 2026 AEST
Key Points
Dr Tara Speranza appointed CEO and CTO
$0.791 million raised via share placement
VB4-P5 renal compound sold to XORTX Therapeutics
Cardinal Health Regulatory Services engaged for FDA interactions
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Vectus Biosystems (ASX:VBS)
OPEN ARTICLE